What does the Metropolis Healthcare Limited (METROPOLIS) stock page cover?

Metropolis Healthcare Limited on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.

What are the current headline metrics for METROPOLIS?

Metropolis Healthcare Limited is currently shown with a delayed price near ₹545.65, P/E 55.99.

Does the METROPOLIS page provide investment advice?

No. The METROPOLIS page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.

Stocks›Healthcare

Watch Alert

Metropolis Healthcare Limited

METROPOLIS · NSE · Healthcare · As of 30 Oct 2026Delayed / Sandbox EOD Data

₹545.65

−₹8.20 (−1.48%)(1D)

₹412.2552 Week Range₹609.05

Anvest Score

51/100

Valuation

0/100

Quality

62/100

Growth

65/100

Health

87/100

Momentum

45/100

Valuation
0
Quality
62
Growth
65
Health
87
Momentum
45

Loading company profile…

More Page Context

Research at a glance

Metropolis Healthcare Limited with delayed price, financials, ownership context, and peer links.

Latest price

₹545.65

Market cap

₹11,403 Cr

P/E ratio

55.99

P/B ratio

7.48

Dividend yield

Not available

ROE

Not available

RSI 14

49.64

1Y return

Not available

Metropolis Healthcare Limited FAQs

3 topics

Expand

Stocks›Healthcare

Watch Alert

Metropolis Healthcare Limited

METROPOLIS · NSE · Healthcare · As of 30 Oct 2026Delayed / Sandbox EOD Data

₹545.65

−₹8.20 (−1.48%)(1D)

₹412.2552 Week Range₹609.05

Anvest Score

51/100

Valuation

0/100

Quality

62/100

Growth

65/100

Health

87/100

Momentum

45/100

Valuation
0
Quality
62
Growth
65
Health
87
Momentum
45

AI Company ProfileSign in to generate AI briefing

AI Snapshot

Metropolis Healthcare Limited is a prominent Indian diagnostic services provider, offering a wide range of clinical laboratory tests and profiles. It operates across India and in select international markets, holding a significant position in the country's growing healthcare diagnostics sector. The company serves individual patients, hospitals, and other healthcare providers.

Diagnostics & ResearchFounded:1980CEO/MD:Ameera ShahHQ:Mumbai, Maharashtra

Business profile as of 2026-08-25

Business at a Glance

The company operates 212 laboratories nationally and 5 internationally, functioning as its primary locations.
Its core business encompasses diagnostic testing, soft radiology services, and clinical trial research services.

Revenue growth: +23.6%FY26 growth+12.8%3Y CAGR
EPS growth: +30.6%FY26 growth+9.7%3Y CAGR
CFO / PAT: 1.85×FY26

What Looks Strong

GrowthRevenue grew at +12.8% CAGR over three years.
Cash FlowOperating cash flow was 1.85× total net profit in FY26.
MarketShareholder returns have comfortably outpaced the Nifty 500 benchmark over the 3-year period.

What to Watch

ValuationThe shares trade at 56× trailing earnings; the multiple assumes sustained high growth and is sensitive to any slowdown.

Reports a single operating segment in its results filings.
Metropolis Healthcare generates revenue by conducting a comprehensive array of diagnostic tests, including routine, specialized, and esoteric tests, for patients, doctors, and hospitals.
It operates through a network of diagnostic centers and collection points, charging fees for its testing services.

FY26 (consolidated): revenue ₹1,646 cr, up 24% from ₹1,331 cr in FY25; net profit ₹190 cr, up 31% from ₹146 cr in FY25.
FY26 (consolidated): operating cash flow ₹351 cr (1.8× net profit); debt/equity 0.10×.
Latest quarter to Jun 2026 (consolidated): revenue ₹450 cr (up 17% year on year); net profit ₹56.9 cr.

Loading company profile…

More Page Context

Research at a glance

Metropolis Healthcare Limited with delayed price, financials, ownership context, and peer links.

Latest price

₹545.65

Market cap

₹11,403 Cr

P/E ratio

55.99

P/B ratio

7.48

Dividend yield

Not available

ROE

Not available

RSI 14

49.64

1Y return

Not available

Metropolis Healthcare Limited FAQs

3 topics

Expand

AI Company ProfileSign in to generate AI briefing

AI Snapshot

Metropolis Healthcare Limited is a prominent Indian diagnostic services provider, offering a wide range of clinical laboratory tests and profiles. It operates across India and in select international markets, holding a significant position in the country's growing healthcare diagnostics sector. The company serves individual patients, hospitals, and other healthcare providers.

Diagnostics & ResearchFounded:1980CEO/MD:Ameera ShahHQ:Mumbai, Maharashtra

Business profile as of 2026-08-25

Business at a Glance

The company operates 212 laboratories nationally and 5 internationally, functioning as its primary locations.
Its core business encompasses diagnostic testing, soft radiology services, and clinical trial research services.

Revenue growth: +23.6%FY26 growth+12.8%3Y CAGR
EPS growth: +30.6%FY26 growth+9.7%3Y CAGR
CFO / PAT: 1.85×FY26

What Looks Strong

GrowthRevenue grew at +12.8% CAGR over three years.
Cash FlowOperating cash flow was 1.85× total net profit in FY26.
MarketShareholder returns have comfortably outpaced the Nifty 500 benchmark over the 3-year period.

What to Watch

ValuationThe shares trade at 56× trailing earnings; the multiple assumes sustained high growth and is sensitive to any slowdown.

Reports a single operating segment in its results filings.
Metropolis Healthcare generates revenue by conducting a comprehensive array of diagnostic tests, including routine, specialized, and esoteric tests, for patients, doctors, and hospitals.
It operates through a network of diagnostic centers and collection points, charging fees for its testing services.

FY26 (consolidated): revenue ₹1,646 cr, up 24% from ₹1,331 cr in FY25; net profit ₹190 cr, up 31% from ₹146 cr in FY25.
FY26 (consolidated): operating cash flow ₹351 cr (1.8× net profit); debt/equity 0.10×.
Latest quarter to Jun 2026 (consolidated): revenue ₹450 cr (up 17% year on year); net profit ₹56.9 cr.

Metropolis Healthcare Limited

Research at a glance

Metropolis Healthcare Limited FAQs

Metropolis Healthcare Limited

Business at a Glance

What Looks Strong

What to Watch

Research at a glance

Metropolis Healthcare Limited FAQs

Related paths

Related insights

VIJAYA

SYNGENE

THYROCARE

How to Analyze an Indian IPO Prospectus (DRHP / RHP) Step by Step Using AI

Business at a Glance

What Looks Strong

What to Watch